Exercise-Induced Coronary Artery Vasodilation Is Not Impaired by Stent Placement-Reference-Cited by-同舟云学术

Exercise-Induced Coronary Artery Vasodilation Is Not Impaired by Stent Placement

Published:2002-05-21 Issue:20 Volume:105 Page:2373-2377
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

Maier Willibald¹,Windecker Stephan¹,Küng Adrian¹,Lütolf Roland¹,Eberli Franz R.¹,Meier Bernhard¹,Hess Otto M.¹

Affiliation:

1. From the Department of Cardiology, Swiss Cardiovascular Center, Bern, Switzerland.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference19 articles.

1. Three-Year Follow-up after Implantation of Metallic Coronary-Artery Stents

2. National Institute for Clinical Excellence. Guidance on coronary artery stents in the treatment of ischemic heart disease. Available at: www.nice.org.uk. Accessed 2000.

3. Long-term endothelial dysfunction after coronary artery stenting

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Angina e isquemia a los 2 años con armazón vascular bioabsorbible y stents farmacoactivos metálicos. Estudio ESTROFA Isquemia AVB-SFAm;Revista Española de Cardiología;2018-05

2. Angina and Ischemia at 2 Years With Bioresorbable Vascular Scaffolds and Metallic Drug-eluting Stents. ESTROFA Ischemia BVS-mDES Study;Revista Española de Cardiología (English Edition);2018-05

3. Dmax for sizing, PSP-1, PSP-2, PSP-3 or OCT guidance: interventionalist’s jargon or indispensable implantation techniques for short- and long-term outcomes of Absorb BRS?;EuroIntervention;2017-04

4. Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial;The Lancet;2016-11

5. Two-year clinical, angiographic, and serial optical coherence tomographic follow-up after implantation of an everolimus-eluting bioresorbable scaffold and an everolimus-eluting metallic stent: insights from the randomised ABSORB Japan trial;EuroIntervention;2016-10